產(chǎn)品詳情
簡單介紹：
Anti-Fragilis抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-Fragilis抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-Fragilis
Cat. Number:
Anti-Fragilis抗體KL-12265R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
IFITM3 is a multi-pass membrane Anti-Fragilis抗體protein that belongs to the IFITM (interferon inducible transmembrane) family of proteins. IFITM proteins are induced by type I and type II interferons and contain multiple interferon (IFN)-stimulated response elements (ISREs) in their promoter regions. IFITM proteins play important roles in many cellular processes and their expression requires the presence of the chromatin remodeling SWI/SNF-like BAF complexes. Cellular processes involving IFITM proteins include cellular anti-proliferative activities and homotypic cell adhesion functions of interferons. In addition, IFITM genes are often upregulated in various cancer cells, suggesting a possible role in carcinogenesis. Localizing to the membrane, IFITM3 is a 133 amino acid protein that is induced by IFN-?and IFN-? IFITM3 expression can be regulated by TEF-1, Brg-1 and Sp1
Also known as:
1 8U; Ifitm 3; Ifitm3; IFM3_HUMAN;Anti-Fragilis抗體 Interferon induced transmembrane protein 3 (1 8U); Interferon Induced Transmembrane Protein 3; Interferon inducible; Interferon inducible protein 1 8U; Interferon Inducible Protein 15; Interferon Inducible Protein Homolog; Interferon-induced transmembrane protein 3; Interferon-inducible protein 1-8U; IP15.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic Anti-Fragilis抗體peptide derived from human Fragilis.
●
Predicted Molecular Weight: 15kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1:20-300 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Fragilis抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Fragilis抗體
Optimal working dilutions must be determined by the end user.
kl902Hu03 心肌鈣黏蛋白(CDHH)多克隆抗體 Polyclonal Antibody to Cadherin, Heart (CDHH)
kl902Hu02 心肌鈣黏蛋白(CDHH)多克隆抗體 Polyclonal Antibody to Cadherin, Heart (CDHH)
kl888Mu02 周期素依賴性激酶1(CDK1)多克隆抗體 Polyclonal Antibody to Cyclin Dependent Kinase 1 (CDK1)
kl866Ra03 神經(jīng)調(diào)節(jié)素1(NRG1)多克隆抗體 Polyclonal Antibody to Neuregulin 1 (NRG1)
kl815Ra05 白介素6受體(IL6R)多克隆抗體 Polyclonal Antibody to Interleukin 6 Receptor (IL6R)
kl805Hu02 高分子量激肽原(HMWK)多克隆抗體 Polyclonal Antibody to High Molecular Weight Kininogen (HMWK)
kl785Hu02 腦啡肽酶(NEP)多克隆抗體 Polyclonal Antibody to Neprilysin (NEP)
kl652Hu02 白介素18受體1(IL18R1)多克隆抗體 Polyclonal Antibody to Interleukin 18 Receptor 1 (IL18R1)
kl650Mu02 主要堿性蛋白(MBP)多克隆抗體 Polyclonal Antibody to Major Basic Protein (MBP)
kl603Hu02 生長調(diào)節(jié)致癌基因β(GROβ)多克隆抗體 Polyclonal Antibody to Growth Regulated Oncogene Beta (GROb)
kl571Hu02 胸腺激活調(diào)節(jié)趨化因子(TARC)多克隆抗體 Polyclonal Antibody to Thymus Activation Regulated Chemokine (TARC)
kl481Mu03 神經(jīng)鈣黏蛋白(CDH2)多克隆抗體 Polyclonal Antibody to Cadherin, Neuronal (CDH2)
kl456Hu02 松弛素/胰島素樣肽受體1(RXFP1)多克隆抗體 Polyclonal Antibody to Relaxin/Insulin Like Family Peptide Receptor 1 (RXFP1)
kl447Ra02 乙酰膽堿酯酶(AchE)多克隆抗體 Polyclonal Antibody to Acetylcholinesterase (AchE)
kl355Mu02 花生四烯酸-5-脂加氧酶(ALOX5)多克隆抗體 Polyclonal Antibody to Arachidonate-5-Lipoxygenase (ALOX5)
kl332Hu02 鳥氨酸脫羧酶(ODC)多克隆抗體 Polyclonal Antibody to Ornithine Decarboxylase (ODC)
kl302Ra02 野鼠色基因相關(guān)蛋白(AGRP)多克隆抗體 Polyclonal Antibody to Agouti Related Protein (AGRP)
